Clinical Trial Update: P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid

View source ↗

Summary

A completed clinical trial from University Hospital, Toulouse evaluated the p75NTR biomarker quantification in cerebrospinal fluid for Alzheimer's disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Alzheimer Disease | Status: COMPLETED